News
The growing prevalence of diabetes, primarily due to obesity, aging populations, and sedentary lifestyles, is a key factor ...
As demand soared for weight-loss drugs, price signals worked.
States increasingly struggling to cover the rising cost of popular GLP-1 drugs like Wegovy, Ozempic and Zepbound are searching for ways to get out from under the budgetary squeeze that took them by ...
The Trump administration has decided not to back a Biden administration plan that would have allowed Medicare to pay for obesity drugs, according to a report from Bloomberg. Shares of both Eli ...
Two Spoons Creamery is launching the first high-protein ice cream with zero added sugar and GLP-1 compatibility in the frozen dairy section. Two Spoons Ice Cream is now available in four incredible, ...
Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today released its 2024 Environmental, Social and Governance (ESG) report. The report ...
More than a dozen vaccination clinics were canceled in Pima County, Arizona. So was a media blitz to bring low-income children in Washoe County, Nevada, up to date on their shots. Planned clinics ...
Novo Nordisk's GLP-1 receptor agonist semaglutide has been shown to help people struggling with alcohol use disorder (AUD) reduce the amount they drink – pointing to yet another potential use ...
Novo Nordisk gets CHMP backing for oral GLP-1 agonist Rybelsus in its marketing battle with Eli Lilly, plus positive opinions for Bayer’s diabetes drug Nubeqa, Emergent’s cholera vaccine, and more ...
News and analysis about trends that affect retirement advisors include the changing workforce demographic, the public's awareness of fiduciary duty, the retirement crisis, the move to MEPs, and ...
Ypsomed and Sidekick Health are launching an integrated digital health solution to better support people with obesity. Ypsomed's autoinjectors seamlessly integrate into Sidekick's digital health and ...
Retirement plan rules, regulations and announcements from the DOL, the IRS, and the SEC help advisors stay in compliance and keep their plan sponsors in compliance. Problems with compliance can ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results